Anxiety, Depression, and Substance Use Disorders
Diagnosis, Treatment, and Prescribing Practices
Bibliographic Data
| ID | 14675997 |
|---|---|
| Authors | Mim J Landry (OASIS Clinic), David E Smith (0000-0003-2791-4964, University of California, San Francisco), John R Steinberg (University of Maryland, Baltimore) |
| Year | 1991 |
| Volume | 23 |
| Issue | 4 |
| Pages | 397-416 |
| Publication date | 1991-10-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Psychoactive Drugs (JOURNAL) |
| Journal identifiers | ISSN: 0279-1072 • E-ISSN: 2159-9777 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/02791072.1991.10471611 |
| PMID | 1813612 |
| OpenAlex | W2007223077 |
| Language | EN |
| Citations received | 4 |
| References cited | 43 |
Attending physicians routinely encounter patients with signs and symptoms of anxiety and mood disorders as well as psychoactive substance use and psychoactive substance-induced organic mental disorders. These symptoms may represent either primary disorders or pathology that is secondary to other disorders. This article describes some of the relationships between substance use disorders and symptoms of anxiety and depressive disorders. In addition, some patients with these disorders may have a concurrent substance use disorder or be at high risk for developing one. Routine treatment of anxiety disorders with psychoactive drugs can be successful in many patients but may lead to iatrogenic dependence in high-risk patients. Prescribing for high-risk patients should include a stepwise treatment protocol having three progressive levels: (1) conservative, nonpharmacological approaches; (2) nonpsychoactive pharmacotherapy, including the use of anxioselective agents, such as buspirone; and (3) psychoactive pharmacotherapy, such as the use of benzodiazepines. Proper prescribing practices for high-risk patients are described in terms of diagnosis, dosage, duration, discontinuation, dependence, and documentation
Anti-Anxiety Agents · Anxiety · Buspirone · Discontinuation · Mood · Mood disorders · Pharmacotherapy · Psychiatry · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · Attention Deficit Hyperactivity Disorder · Medicine · Substance Abuse Treatment and Outcomes · Internal Medicine
Investigation and analysis of factors related to sleep conditions during the acute withdrawal period of alcohol use disorder
Prevalence of Depression and Alcohol and Other Drug Dependence in Addictions Treatment Populations
Background and Overview of Mental Health and Substance Abuse Treatment Systems
Services for Perinatal Women with Substance Abuse and Mental Health Disorders
| Unique citing works | 4 |
|---|---|
| Citations per year | 0,13 |
| Citation span | 1996 - 2025 (30) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 4 |